Resources

The FDA announced today the approval of Januvia (sitagliptin phosphate) Tablets, the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors that enhances the body’s own ability to lower elevated blood sugar.

Results indicate an increased risk of vitamin B12 deficiency associated with current dose and duration of metformin.

New system provides more options for insulin pump users.

With increasing duration of type 2 diabetes it was found that decreases in postprandial insulin secretion are more pronounced.

Nearly one out of two women with gestational diabetes also have periodontal disease.

Averse patients who think they’re getting a free ride by drinking decaf at Starbucks, for instance, should know that it may be laden with the stimulant, claims not withstanding.

Many people with diabetes also have psoriasis, which increases their risk even more then the 3 times greater risk for heart attacks then those without diabetes.

A new class of diabetes drugs appears to hold promise against sepsis, a severe and often fatal reaction of the immune system to infection.

Even though it failed to show any benefit to preventing diabetes, ramipril has many other benefits

Although patients with type 2 diabetes usually experience little anxiety in the first years of their diagnosis, early and intensive treatment can affect patients’ psychological outcomes, resulting in higher anxiety and less self-efficacy.